Ethical and social challenges in newborn screening for prenatal alcohol exposure

Canadian Journal of Neurological Sciences

Volumn 41, Issue 1, 2014, Pages 115-118

  Yan, Allison ^a   Bell, Emily ^a   Racine, Eric ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID ESTER;

ALCOHOL CONSUMPTION; ANAMNESIS; CONFIDENTIALITY; FAMILY; FETAL ALCOHOL SYNDROME; HEALTH BEHAVIOR; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LABORATORY TEST; LONG TERM MEMORY; MATERNAL BEHAVIOR; MECONIUM; MEDICAL ETHICS; MOTHER; NEWBORN SCREENING; NOTE; PARENT; PHYSICIAN; PRACTICE GUIDELINE; PREGNANCY; PRENATAL ALCOHOL EXPOSURE; PRENATAL EXPOSURE; PREVALENCE; PRIVACY; SCREENING; SELF REPORT; VALIDITY; ADVERSE EFFECTS; DIAGNOSIS; DRINKING BEHAVIOR; ECONOMICS; EPIDEMIOLOGY; ETHICS; FEMALE; NEWBORN; SOCIOECONOMICS;

ALCOHOL DRINKING; CONFIDENTIALITY; FEMALE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SOCIOECONOMIC FACTORS;

EID: 84908287447     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100016413     Document Type: Note

References (7)

1. Public Health Agency of Canada. What is fetal alcohol spectrum disorder (FASD)? Public Health Agency of Canada, Ottawa, ON, 2007, Available at: http://www.phac-aspc.gc.ca/hp-ps/dcadea/ prog-ini/fasd-etcaf/publications/pdf/factsheet1-fasd-etcafeng. pdf, accessed August 6, 2013.
2. Joya X, Friguls B, Ortigosa S, et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal. 2012;69:209-22.
3. Canadian Association of Paediatric Health Centres. National screening tool kit for children and youth identified and potentially affected by FASD, Canadian Association of Paediatric Health Centres, Ottawa, ON, 2012, Available at http://ken.caphc.org/xwiki/bin/download/FASDScreeningToolki t/National+Screening+Tool+Kit+for+Children+and+Youth+Ide ntified+and+Potentially+Affected+by+FASD/FASDToolKit-BoundEN.pdf, accessed August 6, 2013.
4. Zizzo N, Di Pietro N, Green C, Reynolds J, Bell E, Racine E. Review and reflections on ethics in screening for biomarkers of prenatal alcohol exposure. Alcohol Clin Exp Res. 2013 Sep;37 (9):1451-5.
5. Dickens BM. Legal and ethical considerations in meconium testing for fetal exposure to alcohol. J Popul Ther Clin Pharmacol. 2011; 18(3):e471-4.
6. Koren G, Hutson J, Gareri J. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther. 2008;83(4): 631-4.
7. Zelner I, Koren G. Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. Ther Drug Monit. 2009; 31(2):170-2.